Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.
BACKGROUND: Infectious complications and associated mortality are a major concern in acute pancreatitis. Enteral administration of probiotics could prevent infectious complications, but convincing evidence is scarce. Our aim was to assess the effects of probiotic prophylaxis in patients with predic...
Váldodahkkit: | Besselink, MG, van Santvoort, H, Buskens, E, Boermeester, M, van Goor, H, Timmerman, H, Nieuwenhuijs, V, Bollen, T, van Ramshorst, B, Witteman, B, Rosman, C, Ploeg, R, Brink, M, Schaapherder, A, Dejong, C, Wahab, P, van Laarhoven, C, van der Harst, E, Eijck, v, Cuesta, M, Akkermans, L, Gooszen, H |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2008
|
Geahča maid
-
[Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial].
Dahkki: Besselink, MG, et al.
Almmustuhtton: (2008) -
Probiotic prophylaxis in patients with predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
Dahkki: Besselink, M, et al.
Almmustuhtton: (2008) -
Probiotic prophylaxis In predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
Dahkki: Besselink, MG, et al.
Almmustuhtton: (2009) -
Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis.
Dahkki: Besselink, MG, et al.
Almmustuhtton: (2009) -
Gastrointestinal permeability and infectious complications in acute pancreatitis; a prospective multicenter study
Dahkki: Besselink, MG, et al.
Almmustuhtton: (2008)